This volume addresses the dynamics of sustainable development in the healthcare industry
covering all major aspects including R&D manufacturing regulation market access
commercialization and general management. Healthcare markets are evolving under demographic
and economic pressures. In mature markets patients navigate complex systems with limited
control on healthcare quality and outcomes while in developing markets patients have limited
awareness access and ability to pay for healthcare. The industry needs to identify which
business targets are genuinely attractive for major or new investments.At the same time
development of new products and services must be tackled within the context of environmental
sustainability. Rather than focusing on the traditional issues of innovation cost management
and commercial effectiveness associated with growth the authors explore such emerging topics
as:The mutations of innovation managementThe need to foster patient-centricity along the entire
value chain of the healthcare industry and company-wideIssues related to improving healthcare
access and disease managementThe allocation of educational resources focused on the patient to
increase the effectiveness of disease managementThe preservation of natural resources and the
environmental effect of pollution and hazards created by the handling of pharmaceutical
productsIssues related to the size of medical need and or market demandThe private-public
partnerships necessary to address the full spectrum of public health issues from basic patient
access to care to managing global health crisesThe required organizational and governance
evolutions for the healthcare industry to maintain profitability and sustainable growth.
Featuring contributions from leading academics and industry insiders with emphasis on
environmental economically and socially sustainable practices the authors present a unique
multi-faceted set of perspectives on this vital and rapidly evolving field.
